thioctic acid and 2,3,4-tri-o-acetylarabinopyranosyl isothiocyanate

thioctic acid has been researched along with 2,3,4-tri-o-acetylarabinopyranosyl isothiocyanate in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ceruti, S; Di Cesare Mannelli, L; Francesconi, O; Ghelardini, C; Gualdani, R; la Marca, G; Magni, G; Merli, D; Moncelli, MR; Nativi, C; Richichi, B1

Other Studies

1 other study(ies) available for thioctic acid and 2,3,4-tri-o-acetylarabinopyranosyl isothiocyanate

ArticleYear
Lipoic-based TRPA1/TRPV1 antagonist to treat orofacial pain.
    ACS chemical neuroscience, 2015, Mar-18, Volume: 6, Issue:3

    Topics: Animals; Anti-Inflammatory Agents; Calcium Channels; CHO Cells; Cricetulus; Dose-Response Relationship, Drug; Facial Pain; Glial Fibrillary Acidic Protein; Humans; Isothiocyanates; Nerve Tissue Proteins; Patch-Clamp Techniques; Rats; Thioctic Acid; Transfection; Transient Receptor Potential Channels; TRPA1 Cation Channel; TRPV Cation Channels

2015